Key result
~74% of arrhythmia patients pursue genetic testing to explain sudden death, relieve uncertainty, and guide management.
Why the study?
Genetic testing for cardiac channelopathies is increasingly available, but understanding individuals' motivations to pursue testing in the context of personal or family history of cardiac events is needed.
Observational (n=50)
Understanding patients' internal and external motivations for or against genetic testing can enhance the genetic counseling and informed consent process in cardiac channelopathies.
May enhance counseling by addressing motivations and barriers; leaves open effects on testing uptake in channelopathy families.
Genetic testing is becoming increasingly available for cardiac channelopathies, such as long QT syndrome and Brugada syndrome, which can lead to sudden cardiac death. Test results can be used to shape an individual's medical management and to identify at-risk family members. In our qualitative study, all participants had a personal or family history of a diagnosed cardiac arrhythmia syndrome or sudden cardiac death. Open-ended interviews were conducted individually and in focus groups. Interviews were audio recorded, transcribed verbatim, and analyzed using a qualitative grounded-theory approach. Of 50 participants, 37 described their motivations for pursuing genetic testing for long QT syndrome or another cardiac channelopathy. Participants' motivations included: to find an explanation for a family member's sudden death, to relieve uncertainty regarding a diagnosis, to guide future medical management, to allay concern about children or other family members, and to comply with recommendations of physicians or family members. Perceived reasons not to pursue genetic testing included denial, fear, and lack of information. The genetic counseling and informed consent process can be enhanced by understanding and addressing an individual's internal and external motivations either for or against pursuing genetic testing.
No takes yet. Share an insight, caveat, or question.
Erskine et al. (2014) conducted an observational in Personal or family history of a diagnosed cardiac arrhythmia syndrome or sudden cardiac death (n=50). Genetic testing was evaluated on Motivations for pursuing or not pursuing genetic testing. Of 50 participants with a history of cardiac arrhythmia syndromes, 37 described motivations for genetic testing, including explaining sudden death, relieving uncertainty, and guiding management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: